
Asuragen develops and manufactures diagnostic tools for the molecular diagnostics laboratory, with a primary focus on oncology applications. Products within Asuragen’s oncology portfolio include multiplexed assays performed on the Luminex under the Signature brand, an easy to use, medium density liquid-based array platform. Multiplexing allows for simultaneous detection of multiple mutations or translocations, offering a comprehensive diagnostic summary while reducing the amount of repeat and reflex testing necessary.